Elon Musk’s Neuralink gets FDA green light for second patient
14178 Tuesday, 21 May, 2024, 10:24 The U.S. Food and Drug Administration gave a green light to Elon Musk’s Neuralink to implant its brain chip in a second person, signing off on the company’s proposed fixes for a problem that occurred in the first test participant. Earlier this month, Neuralink said tiny wires implanted in the brain of its first patient had pulled out of position. Reuters reported last week, citing sources, the company knew from animal testing that the wires might retract. The company intends to fix the problem by embedding some of the device's wires deeper into the brain, the WSJ report said citing a person familiar with the company and a document it had viewed. |
Apple debuts iPhone 16 Pro and iPhone 16 Pro Max (photo)
112810.09.2024, 00:42US, Britain, EU sign world's first AI treaty
131906.09.2024, 22:24Elon Musk reveals second Neuralink participant plays Counter-Strike with his mind (video)
193322.08.2024, 17:18Apple’s first foldable iPhone could arrive in 2026
750325.07.2024, 00:48Geomagnetic warning: Scientists informed about auroras on July 24
732224.07.2024, 10:24Tesla to have humanoid robots for internal use next year, Musk says
753323.07.2024, 15:24Matenadaran has signed an agreement of collaboration with the Belgian publishing house Brepols
551111.07.2024, 01:18Elon Musk’s Neuralink gets FDA green light for second patient
1417821.05.2024, 10:24